Legacy Technology Holdings Inc
Legacy Technology Holdings, Inc. develops and commercializes a web-based genomic preventative medicine and medical software solution. It uses algorithms to analyze data on individual patient's lifestyle factors, such as blood tests, biometrics, diet, environmental, nutraceutical, pharmaceutical, and genetic makers. The company was incorporated in 2012 and is based in Arvada, Colorado.
Legacy Technology Holdings Inc (LTHO) - Net Assets
Latest net assets as of September 2013: $14.46K USD
Based on the latest financial reports, Legacy Technology Holdings Inc (LTHO) has net assets worth $14.46K USD as of September 2013.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($14.47K) and total liabilities ($10.00). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.46K |
| % of Total Assets | 99.93% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Legacy Technology Holdings Inc - Net Assets Trend (2012–2020)
This chart illustrates how Legacy Technology Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Legacy Technology Holdings Inc (2012–2020)
The table below shows the annual net assets of Legacy Technology Holdings Inc from 2012 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | $-291.48K | -17.47% |
| 2019-12-31 | $-248.13K | +86.65% |
| 2012-12-31 | $-1.86 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Legacy Technology Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 133367600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $7.27K | % |
| Other Comprehensive Income | $707.35K | % |
| Other Components | $708.00K | % |
| Total Equity | $-291.48K | 100.00% |
Legacy Technology Holdings Inc Competitors by Market Cap
The table below lists competitors of Legacy Technology Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Highland Surprise Consolidated Mining Co
PINK:HSCM
|
$2.90 |
|
Eyecity.Com Inc
PINK:ICTY
|
$2.90 |
|
American Green Inc
PINK:ERBB
|
$2.91 |
|
FirsTime Design Ltd
PINK:FTDL
|
$2.91 |
|
Arkose Energy Corp
PINK:RKOS
|
$2.89 |
|
REAC Group Inc
PINK:REAC
|
$2.87 |
|
LEHMAN BROTHERS HOLDINGS CAP TS
PINK:LEHKQ
|
$2.86 |
|
Fernhill Corp
PINK:FERN
|
$2.86 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Legacy Technology Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from -248,132 to -291,482, a change of -43,350.
- Net loss of 123,043 reduced equity.
- Other comprehensive income decreased equity by 7,912.
- Other factors increased equity by 87,605.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-123.04K | -42.21% |
| Other Comprehensive Income | $-7.91K | -2.71% |
| Other Changes | $87.61K | +30.06% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Legacy Technology Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $0.00 | $0.00 | x |
| 2020-12-31 | $0.00 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Legacy Technology Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is below the historical average (0.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2010 | 0.00% | 0.00% | 0.00x | 0.00x | $28.34K |
| 2011 | 0.00% | 0.00% | 0.00x | 0.00x | $30.36K |
| 2012 | 0.00% | 0.00% | 0.00x | 0.00x | $8.58K |
| 2019 | 0.00% | 0.00% | 0.00x | 0.00x | $19.40K |
| 2020 | 0.00% | 0.00% | 0.00x | 0.00x | $-93.89K |
Industry Comparison
This section compares Legacy Technology Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Legacy Technology Holdings Inc (LTHO) | $14.46K | 0.00% | 0.00x | $2.89 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |